Condition

Clinical trials for Obesity &Amp; Overweight

Active public studies that list Obesity &Amp; Overweight as a condition.

33active studies

13recruiting now

14countries represented

2largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowNot applicable

Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment

Obesity &Amp; Overweight, Digestive DisordersCondition

Probiotics (Natural product), PlaceboTreatment

France1 locations

Hospices Civils de LyonSponsor

Updated 2026-08-19 · NCT07213323See eligibility →

Recruiting nowNot applicable

Effects of Grape Consumption on the Immune-Gut Axis in Obesity

Obesity &Amp; OverweightCondition

Freeze-dried grape powder, Placebo powderTreatment

United States1 locations

University of Missouri-ColumbiaSponsor

Updated 2026-07-31 · NCT07231484See eligibility →

Recruiting nowNot applicable

Training App for Inhibitory Control Towards Food

Obesity &Amp; Overweight, Bulimia NervosaCondition

Food-specific inhibitory control training delivered through the FoodTraining App, Waiting listTreatment

Italy1 locations

University of PadovaSponsor

Updated 2025-12-30 · NCT07075952See eligibility →

Recruiting nowNot applicable

A Prospective Randomnised Controlled Trial Comparing Overall Patient Compliance in a Bariatric Surgical Pathway Using the Standard Versus a More Intensified and Interactive Version of the "Get Ready" Smartphone Application.

Obesity &Amp; Overweight, HypertensionCondition

GetReady application, Intensified GetReady applicationTreatment

Belgium1 locations

Sint Dimpna Ziekenhuis GeelSponsor

Updated 2025-12-22 · NCT07297342See eligibility →

Recruiting nowPhase 2

UBT251 Injection Phase II Clinical Study (CKD)

Obesity &Amp; Overweight, Chronic Kidney DiseaseCondition

UBT251, UBT251Treatment

China1 locations

The United Bio-Technology (Hengqin) Co., Ltd.Sponsor

Updated 2025-11-25 · NCT07134335See eligibility →

Recruiting nowPhase 1, Phase 2

Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity

Obesity &Amp; OverweightCondition

RN3161, Placebo ControlTreatment

Australia1 locations

Ikaria Bioscience Pty LtdSponsor

Updated 2025-11-24 · NCT07245771See eligibility →

Recruiting nowNot applicable

Spontaneous Breathing Trials Using Pressure Support or T-Piece in Overweight and Obese Patients

Mechanical Ventilation, ExtubationCondition

Spontaneous breathing trial using pressure support ventilation, Spontaneous breathing trial using T-PieceTreatment

Taiwan1 locations

Taipei Medical University HospitalSponsor

Updated 2025-11-17 · NCT07114289See eligibility →

Recruiting nowPhase 1, Phase 2

Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment

Obesity &Amp; OverweightCondition

Liver-Expressed Antimicrobial Peptide 2 (LEAP2), Placebo (saline)Treatment

Denmark1 locations

University Hospital, Gentofte, CopenhagenSponsor

Updated 2025-09-18 · NCT07171723See eligibility →

Recruiting nowNot applicable

Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients

Coronary Artery Disease, Diabete MellitusCondition

Intervention not listedTreatment

China1 locations

Xijing HospitalSponsor

Updated 2025-09-18 · NCT07180368See eligibility →

Recruiting nowNot applicable

Behavioral Therapy and GLP-1 Analogue Effects on Binge Eating, Weight, and Coping in Obesity

Binge Eating Disorder Associated With Obesity, Binge Eating DisorderCondition

GLP-1, CBTe Group TherapyTreatment

Norway1 locations

Haukeland University HospitalSponsor

Updated 2025-09-15 · NCT07042672See eligibility →

Recruiting nowNot applicable

Precise Eating Time to Improve Glycemic Control and Cardiometabolic Health in Prediabetes and Diabetes

Prediabetes, Type 2 DiabetesCondition

Early Time-Restricted Eating, Late Time-Restricted EatingTreatment

Germany1 locations

German Institute of Human NutritionSponsor

Updated 2025-09-12 · NCT07171281See eligibility →

Recruiting nowNot applicable

Fueling Strong Hearts for a Strong South Carolina

Stroke, Obesity &Amp; OverweightCondition

Strong SC, StrongPeople StrongHeartsTreatment

United States1 locations

Clemson UniversitySponsor

Updated 2025-08-26 · NCT07140952See eligibility →

Recruiting nowNot applicable

Evaluation of the Care Provided to Patients Who Underwent Bariatric Surgery and Were Lost to Follow-up 5 Years After Surgery

Obesity &Amp; OverweightCondition

Intervention not listedTreatment

France2 locations

Central Hospital, Nancy, FranceSponsor

Updated 2025-08-12 · NCT07118540See eligibility →

Opening soonPhase 2

Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer

Rectal Cancer Patients, Obesity &Amp; OverweightCondition

GLP-1 receptor agonist, Total neoadjuvant therapy (TNT)Treatment

Locations pending0 locations

St. James's Hospital, IrelandSponsor

Updated 2026-01-02 · NCT07314528See eligibility →

Opening soonPhase 3

Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus

Obesity &Amp; OverweightCondition

IN-B00009, PlaceboTreatment

Locations pending0 locations

HK inno.N CorporationSponsor

Updated 2025-09-25 · NCT07192263See eligibility →

Opening soonNot applicable

Validation of Heart Rate Monitors in Overweight and Obese Young Adults

Obesity &Amp; OverweightCondition

Intervention not listedTreatment

Locations pending0 locations

Universidad Autonoma de Baja CaliforniaSponsor

Updated 2025-09-19 · NCT07184177See eligibility →

Opening soonNot applicable

Effectiveness of a Family Support Model for Prevention and Management of Overweight and Obesity in Children 6-12 Years

Obesity &Amp; OverweightCondition

More and LessTreatment

Sweden1 locations

Karolinska InstitutetSponsor

Updated 2025-09-17 · NCT07158944See eligibility →

Opening soonNot applicable

The Impact of a Weight Reduction Intervention on Clinical Outcomes in Patients With Obesity and COPD

COPD, Obesity &Amp; OverweightCondition

Energy restrictionTreatment

Locations pending0 locations

Sahlgrenska University HospitalSponsor

Updated 2025-09-08 · NCT07159594See eligibility →

Opening soonNot applicable

The Resistant Starch Intervention for Cognitive Enhancement

Cognitive Impairment, Diet InterventionsCondition

High resistant starch staple foods, Regular starch staple foodsTreatment

China1 locations

Second Affiliated Hospital, Zhejiang University, School of MedicineSponsor

Updated 2025-09-03 · NCT07152483See eligibility →

Opening soonNot applicable

The MB-EAT Smart Teen Study

Obesity &Amp; OverweightCondition

MB-EAT program, Feasibility studyTreatment

Canada1 locations

Gary GoldfieldSponsor

Updated 2025-08-19 · NCT07130838See eligibility →

Opening soonNot applicable

Proof of Concept in the Prevention of Post-bariatric Sarcopenia: Simulated Activation of the "Gravitostat"

Obesity &Amp; Overweight, Bariatric SurgeryCondition

maintaining mechanical loadTreatment

France1 locations

University Hospital, Clermont-FerrandSponsor

Updated 2025-08-13 · NCT07120685See eligibility →

Opening soonPhase 4

PHArmaCokinetics of methYLphenidate in Adult Patients With Attention-Deficit /Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder (ADHD), Obesity (Body Mass Index &Amp;Amp;gt;30 kg/m2)Condition

PHArmacoKinetics of methYLphenidate in adult patients with ADHD: comparison between patients with and without OBesity.Treatment

France1 locations

University Hospital, ToursSponsor

Updated 2025-08-13 · NCT07121621See eligibility →

Opening soonPhase 1

Phase Ib Clinical Study on the Efficacy and Safety of MDR-001 in Patients Who Are Obesity or Overweight

Obesity &Amp; OverweightCondition

MDR-001, PlaceboTreatment

China1 locations

MindRank AI LtdSponsor

Updated 2025-08-08 · NCT07110766See eligibility →

Active, not recruitingNot applicable

E-Bike Commuting and Health in Overweight College Students

Obesity &Amp; Overweight, Sedentary BehaviorsCondition

E-Bike CommutingTreatment

United States1 locations

University of Wisconsin, River FallsSponsor

Updated 2026-07-20 · NCT07114991See eligibility →

Active, not recruitingNot applicable

Can Gut Bacteria Predict Who Benefits Most From Exercise? A Gut Supplement to Help Exercise Non-Responders

Obesity &Amp; OverweightCondition

Cardiovascular Exercise, ButyrateTreatment

United States1 locations

Texas Christian UniversitySponsor

Updated 2026-05-27 · NCT07180446See eligibility →

Active, not recruitingNot applicable

Soup and Bread Recipe Impacts on Ingestive Behavior

Obesity &Amp; OverweightCondition

Chia seeds, Hemp seedsTreatment

United States1 locations

USDA Beltsville Human Nutrition Research CenterSponsor

Updated 2026-04-28 · NCT07146958See eligibility →

Active, not recruitingNot applicable

Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)

Alzheimer Disease (AD), Cardio Vascular DiseaseCondition

Intervention not listedTreatment

United States1 locations

Marymount UniversitySponsor

Updated 2026-03-09 · NCT07180147See eligibility →

Active, not recruitingNot applicable

The Impact of Probiotics on Bariatric Treatment Outcomes

Obesity &Amp; OverweightCondition

Probiotic, DietTreatment

Poland1 locations

University of Warmia and Mazury in OlsztynSponsor

Updated 2025-12-02 · NCT07258732See eligibility →

Active, not recruitingNot applicable

An Evaluation of "Growing Healthy Places: Mississauga"

Quality of Life (QOL), Physical ActivityCondition

Community Co-designed Physical Activity and Diet Intervention PackageTreatment

Canada1 locations

Brock UniversitySponsor

Updated 2025-11-21 · NCT07191925See eligibility →

Active, not recruitingNot applicable

Fat Around Heart Arteries as a Measure of Inflammation in Patients With Glycometabolic Disease

Obesity &Amp; Overweight, Obesity Type 2 Diabetes MellitusCondition

Intervention not listedTreatment

Denmark1 locations

Odense University HospitalSponsor

Updated 2025-08-27 · NCT07144670See eligibility →

Active, not recruitingNot applicable

Mediterranean-DASH Intervention for Neurodegenerative Delay and High-Intensity Interval Training in Adults With Hypertension

Hypertension (HTN), Obesity &Amp; OverweightCondition

MIND HIITTreatment

United States1 locations

Texas Woman's UniversitySponsor

Updated 2025-08-19 · NCT07130539See eligibility →

Active, not recruitingNot applicable

Organic Pollutant Build-Up in Body Fat and Stomach Tissue Linked to Obesity Levels

Obesity &Amp; OverweightCondition

exposure to organic pollutantTreatment

China1 locations

Dong PengSponsor

Updated 2025-08-17 · NCT07126743See eligibility →

Active, not recruitingNot applicable

The Mauritius and Rodrigues Non-Communicable Disease (NCD) Study

Diabete Mellitus, Cardiovascular Disease Risk FactorCondition

Intervention not listedTreatment

Mauritius1 locations

Umeå UniversitySponsor

Updated 2025-07-17 · NCT07048717See eligibility →

Related conditions

Obesity1,102 Obesity & Overweight220 Overweight205 Overweight and Obesity130 Type 2 Diabetes108 Hypertension107

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.